Albaracin, Richard R.
HRN: 26-02-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/16/2024
10/23/2024
IV
4.5g
Q8
Complicated Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes